Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 4
Submit an article Journal homepage
125
Views
49
CrossRef citations to date
0
Altmetric
Research Article

Phase II Study of Fludarabine, Cytarabine (Ara-C), Cyclophosphamide, Cisplatin and GM-CSF (FACPGM) in Patients With Richter's Syndrome or Refractory Lymphoproliferative Disorders

Apostolia M. Tsimberidou Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
,
Susan M. O'Brien Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
,
Jorge E. Cortes Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
,
Stefan Faderl Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
,
Michael Andreeff Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
,
Hagop M. Kantarjian Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
,
Michael J. Keating Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
&
Francis J. Giles Department of Leukemia, Box 428, University of Texas, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX 77030, USA
 show all
Pages 767-772 | Published online: 01 Jul 2009

  • Kernan, N.A., Bartsch, G., Ash, R.C., Beany, P.O., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J. and McCullough, J. (1993) "Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program", N. Engl. J. Med., 328, 593-602.
  • Balduzzi, A., Gooley, T., Anaselli, C, Sanders, J.E., Martin, P.J., Pelersdorf, E.W. Appelbaum, F.R., Buckner, C.D., Matthews, D. and Storb, R. (1995) "Unrelated donor marrow transplantation in children", Blood 86, 3247-3256.
  • Gluckman, H., Rocha, V., Boyer-Chaiumard, A., Locatelli, F. Arcese, W., Pasquiai, R., Ortega, J., Souillet., G., Ferreira, E., Laporte, J.P., Fernandez, M. and Chastang, C. (1997) "Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Trarsplantation Group", N. Eng. J. Med. 337, 373-381.
  • Hausen, J.A., Gooley, T.A., Martin, P.J., Appelbaum, F., Chaunceym T.R., Clift, R.A., Petersdorf, E.W., Radich, J., Sanders, J.E.,. Storh, R.F., Sullivan, K.M. and Anasetti, C., (1998) "Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia". N. Engl. J. Med. 338, 962-968.
  • Kurtzberg, J., Laughlin, M., Graham, M.L., Smith, C., Olson, J.F., Halperin, E.C., Ciocci, G., Carrier, C., Stevens, C.E. and Rubinstein, P. (1996) "Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients". N. Engl. J. Med. 335, 157-166.
  • Rubinstein, P., Carrier, C., Scaradavou, A., Kurtzherg, J., Adamson, J., Migliaccio, A.R., Berkowitz, R.L., Cabbad, M., Dobrila, N.L., Taylor, P.E., Rosenfield, R.E. and Stevens, C.E. (1998) "Outcomes among 562 recipients of placental-blood transplants from unrelated donors", N. Engl. J. Med. 339, 1565-1577.
  • Speiser, D.E., Tiercy, J.M., Rufer, N., Grundschober, C., Gratwohl, A., Chapuis, B., HeIg, C., Loliger, C.C., Siren, M. K., Roosnek, E. and Jeannet, M. (1996) "High resolution HLA matching associated with decreased mortality after unrelated bone marrow trans plantation", Blood 87, 4455-4462.
  • Davies, S.M., Shu, X.O., Blazar, B.R., Filipovich, A.H., Kersey, J.H., Krivit, W. McCuIlough, J., Miller, W.J., Ramsay, N.K. and Segall, M. (1995) 'Unrelated donor bone marrow transplantation: influence of HLA A and B incompatibility on outcome", Blood 86, 1636-1642.
  • Pelersdorf, E.W., Longton, G. M., Anasetti, C., Martin, P.J., Mickelson, E.M., Smith, A.G. and Hansen, J.A. (1995) "The significance of HLA-DRB1 matching on clinical outcome alter HLA A, B. DR identical unrelated donor marrow transplantation", Blood, 1606-1613.
  • Small, T.N., Papadopoulos, K.B., Boulad, F., Black, P. Castro -Malaspina, H., Childs, B.H., Collins, N., Gillio, A., George, D., Jakubowski, A., Heller, G., Pazzuri, M., Kernan, N., MacKinnon, S., Szuboles, P. Young, J.W. and O'Reilly, R.J. (1999) "Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions". Blood 93, 467-480
  • Kook, H., Goldman, F., Padley, D., Culler, R., Rumelhart, S., Holida, M., Lee, N., Peters, C., Comito, M., Huling, D. and Trigg, M. (1996) "Reconstruciion of the immune system after unrelated or partially matched T-cell-depIeted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery". Blood 88, 1089-1097.
  • Bonno, M., Azuma, E., Nakano, T., Higashikawa, M., Kawasaki, H., Nisnihara, H., Obata, M., Umemoto, M., Sakatoku, H., Komaila, Y., lto, M., Kagai, M. and Sakurai, M. (1997) "Successful hematopoietic recunstitution by transplantation of umbilical cord blood cells in a transfusion-dependent child with Diamond -Blaekfan anemia", Bone Marrow Transplant. 19, 83-85.
  • Azuma, E., Hirayama, M., Bonnu, M., Iwamoto, S., Kumamoto, T., Kohayushi, M., Komada, Y., Taniguchi, K., Nakano, T. and Kamiya, H. (2001) "Successful immunization following cord blood transplantation in a child with Diamond-Blackfan anemia", Pediatr. Hematol. Oncol. 18, 193-197.
  • Davenport, C., Kumar, V. and Bennett, M. (1993) "Use of newborn liver cells as a murine model for cord blood cell transplantation", J. Immunol. 151, 1597-1605.
  • Hirayama, M., Genyea, C., Brownell, A. and Kaplan, J. (1998) "IL-2-activated murine newborn liver NK cells enhance engraft ment of hematopoietic stem cells in MHC-mismaiched recipients". Bone Marrow Transplant. 21, 1245-1252.
  • Scaradavou, A., Isola, L., Rubinstein, P., Galperin, Y., Najfeld, V., Berlin, D., Gordon, J. and Weinberg, R.S. (1997) "A murine model for human cord blood transplantatation: near-term fetal and neonatal peripheral blood cells can achieve long term bone marrow engraftment in sublethally irradiated adult recipients". Blood 89, 1089-1099.
  • Hirayama, M., Azuma, E., Jiang, Q., Kobayashi, M., Iwamoto, S., Kumamoto, T., Kisenge, R., Yamamoto, H. and Komada, Y. (2000) "The reconstitution of CD45RBhiCD4+ naive T-cells is inversely correlated with donor age in murine allogeneic haematopoietic stem cell transplantation", Br. J. Haematol. 111, 700-707.
  • Offner, F., Kerre, T., De Smedt, M. and Plum, J. (1999) "Bone marrow CD34 cells generate fewer T-cells in vitro with increasing age and following chemotherapy", Br. J. Haematol. 104, 801-808.
  • Eren, R., Zharhary, D., Abel, L. and Globerson, A. (1988) "Age -related changes in the capacity of bone marrow cells to differentiate in thymic organ cultures", Cell Immunol. 112, 449-455.
  • Lee, W.T., Yin, X.M. and Vitetta, E.S. (1990) "Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T-cells", J. Immunol. 144, 3288-3295.
  • Nagelkerken, L., Henogh-Huijbregts, A., Dobber, R. and Drager, A. (1991) "Age related changes in lymphokine production related to a decreased number of CD45RBhi CD4+ T-cells". Eur. J. Immunol. 21, 273-281.
  • Rufer, N., HeIg, C., Chapuis, B. and Roosnek, H. (2001) "Human memory T-cells: lessons from stem cell transplantation". Trends Immunol. 22, 136-141.
  • Paulin, T., Ringden, O. and Nilsson, B. (1987) "Immunological recovery alter bone marrow transplantation: role of age, graft -versus-host disease, prednisolone treatment and infections". Bone Marrow Transplant. 1, 317-328.
  • Kawamoto, H., Ohmura, K., Hattori, N. and Katsuia, Y. (1997) "Hemopoietic progeiutors in the murine fetal liver capable of rapidly generating T-cells", J. Immunol. 158, 3118-3124.
  • Mackall, C.L., Granger, L. Sheard, M.A., Cepeda, R. and Gress, R.E. (1993) "T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny", Blood 82, 2585-2594.
  • Mackall, C.L., Fleisher, T.A., Brown, M.R., Andrich, M.P., Chen, C.C., Feuerstein, I.M., Horowitz, M.E., Magrath, I.T., Shad, A.T. and Steinberg, S.M. (1995) "Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy", N. Engl. J. Med. 332, 143-149.
  • Weinberg, K., Blazar, B.R., Wagner, J.E., Agura, H., Hill, B.J., Smogorzewska, M., Koup, R.A., Betts, M.R., Collins, R.H. and Douck, D.C. (2001) "Factors, affecting thymic function after allopeneic hematopoietic stem cell transplantation". Blood 97, 1458-1466.
  • Heitger, A., Neu, N., Kem, H., Hanzer-Grumayer, E.R., Greinix, H., Nachbaur, D., Niedereieser, D. and Fink, P.M. (1997) "Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation", Blod 90, 850-857.
  • Wolf, H.M., Eibl, M.M., Georgi, E., Samstag, A., Spatz, M., Uranus, S. and Passl, R. (1999) "Long-term decrease of CD4+CD45RA+ T-cells and impaired primary immune response after post-traumatic splenectomy (In Process Citation)", Br. J. Haematol. 107, 55-68. References
  • Willemze, R., Kerl, H., Sterry, W., Berti, E., Cerrom, L., Chitnenti, S., Diaz-Perez, J.L., Geerts, M.L., Goos, M., Knobler, R., Ralfkiaer, E., Samucci, M., Smith, N., Wechsler, J., van Violen, W.A. and Meijer, C.J. (1997) "EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for research and treatment of Cancer", Blood 90, 354-371.
  • Jahn, S., Asadullah, K., Waiden, P. and Sterry, W. (1998) "Cutaneous malignant lymphomas", Immunology Totay 19, 100-102.
  • Rook, A.H., Gotlieb, S.L., Wolfe, J.T., Vowels, B.R., Sood, S.S., Niu, Z., Lessin, S.R. and Fox, E.E. (1997) "Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis", Clinical and Exper mental Immunology 107, 16-20.
  • Siegel, R.S., Pandolfino, T., Guitart, J., Rosen, S. and Kuzel, T.M. (2000) "Primary cutaneous T-cell lymphoma review and current concepts", Journal of Clinical Oncology 18, 2908-2925.
  • Bagot, M., Weschler, J., Lees, M.C., Revuz, J., Parcel, J.P. and Gaulard, P. (1992) "Intra-epidermal localization of the clone in the cutaneous T-cell lymphoma", Journal of the American Academy of Dermatology 27, 589-593.
  • Edelman, J. and Meyerson, H.J. (2000) "Diminished CD3 expression is useful for detecting and enumerating Sezary cells", American Journal of Clinical Pathology 114, 467-477.
  • Rappl, G., Muche, J.M., Abken, H., Sterry, W., Tilgen, W., Ugurel, S. and Reinhold, U. (2001) "CD4(+)CD7(-) T-cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome", Journal of the American Academy of Dermatology 44, 456-461.
  • Laetsch, B., Haffner, A.C., Dobbeling, U., Seifert, B., Ludwig, E., Burg, G. and Dummer, R. (2000) "CD4+/CD7 T-cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T-cell lymphomas". The Journal of Investigative Dermatology 114, 107-113.
  • Jones, D., Dang, N.H., Duvic, M., Washington, L.T. and Huh, Y.O. (2001) "Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood", American Journal of Clinical Pathology 115, 885-892.
  • Bernengo, M.G., Novelli, M., Quaglino, P., Lisa, E., De Malleis, A., Savoia, R., Cappello, N. and Fierro, M.T. (2001) "The relevance of the CD4+ CD28 subset in the identification of circulating Sezary cells", The British Journal of Dermatology 144, 125-135.
  • Dercure, O., Portales, P.,Clot, J. and Guilhou, J.J. (2001) "Decreased expression of Fas (APO-1/CD95) on peripheral blood OD4- T-lymphocytes in cutaneous T-cell lymphomas", The British Journal of Dermatology 143, 1205-1210.
  • Zoi-Toli, O., Vermeer, M.H., De Vries, E., Van Beck, P. Meijer, C.J. and Willeinze, R. (2000) "Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL) association between lack of Fas expression and aggressive types of CTCL", The British J ournal of Dermatology 143, 313-319.
  • Dummer, R., Nestle, F.O., Niederer, E. Ludwig, E., Ladwig, L., Grundmann, H., Grob, P. and Burg, G. (1999) "Genotypic, phenotypic and functional analysis of CD4+ CD7- and CD4+CD7- T-lymphocyte subsets in Sezary syndrome", Archieves of Dermatological Research 291, 307-311.
  • Russell-Jones, R. and Whittaker, S. (1999) "T-cell receptor gene analysis in the diagnosis of Sezary syndrome". Journal of the American Academy of Dermatology 41, 254-914.
  • [15| Dadej, K., Gaboury, L., Lamarre, L., Petorin, C., Seguin, C., Cadotte, M. and Gorska-Flipot, I. (2001) "The value of clonality in the diagnosis and follow-up of patients with cutaneous T-cell infiltrates", diagnostic Molecular Pathology 10, 78-88.
  • Deltan-Larue, M.H., Laroche, L., Wechsler, J., Lepage, E., Lahet, C., Asso-Bonnet, M., Bagot, M. and Fareet, J.P. (2000) "Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma", Blood 96, 2987-2992.
  • Bagot, M., Echechakir, H., Mami-Chouaib, E., Delfau-Larue, M.H., Charue, D., Bernheim, A., Chouaib, S., Boumsell, L. and Bensussan, A. (1995) "Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma", Blood 91, 4331-4341.
  • Poszepczynska, E., Bagoi, M., Echchakir, H., Martimalet, D., Ramez, M., Charue, D., Boumsell, L. and Benstissan, A. (2000) "Functional characterization of an lL-7-dependent CD4(+)CD8al phaalphal+) Th3-type malignant cell line denied from a patient with a cutaneous T-cell lymphoma", Blood 96, 1056-1063.
  • Bagoi, M., Moretta, A., Sivori, S., Biassoni, R., Cantoni, C., Bollino, C., Boumsell, L. and Bensussan, A. (2001) "CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor", Blood 97, 1388-1912.
  • Nikolova, M., Tawab, A., Marie Cardine, A., Bagot, M., Boumsell, L. and Bensussan, A. (2001) "Increased expression of a novel early activation surface membrane receptor in cutaneous T-cell lymphoma cells", The Journal of Investigative Dermatology 116, 731-738.
  • Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., di Donato, C., Accaine, L., Bottino, C., Moretta, A. and Morella, L. (1996) "The natural killer cell receptor specific for HLA-A allotypes: a novel memher of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked domer", The Journal of Experimental Medicine 184, 505-518.
  • Dohring, C., Scheidegger, D., Samaridis, J., Cella, M. and Colonna, M. (1996) "A human killer inhibitory receptor specific for HLA -AL2". The Journal of Immunology 156, 3098-3103.
  • Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M.C. and Moretta, L. (1997) "Major histocompatibility complex class 1-specific receptors on human natural killer and T-lymphocytes", Immunological Reviews 155, 105-117.
  • Mingun, M.C., Moretta, A. and Moretta, L. (1998) "Regulation of KIR expression in human T-cells: a safety mechanism that may impair protective T-cell responses", Immunolgy Today 19, 153-157.
  • Gardiner, C.M., Guethlem, L.A., Shilling, H.G., Pando, M. Carr, W.H., Rajalingam, R., Vilches, C. and Parham, P. (2001) "Different NK cell surface phenotypes defined by DX9 antibody are due to KIR3DLI gene polymorphism", The Journal of Immunology 166, 2992-3001.
  • Nikoiova, M., Tawab, A., Mane-Cardine, A., Bapot, M., Boumsell, l. and Bensussan, A. (in press). "SC5, a novel early activation surface antigen inhibits the CD3/CD28 induced proliferation of T-cells" In Leurovate Typing VII. White Cell Differentiation antigens in Press).
  • Choo, Q, Weiner, A.J., Overby, L.R., Kuo, G., Houghton, M. and Bradley, D.W. (1990) "Hepatitis C virus: the major causative agent of viral non-A, non-B hepatilis", Br Med Bull 46, 423-441.
  • Alter, H.J. (1995) "To C or not to C: these are the questions". Blood 85, 1681-1695.
  • Ferri, C., La Civita, L., Longobardo, G., Zignego, A.L. and Pasero, G. (1998) "Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders", Lupus 7, 275-279.
  • Perl, A., Gorevic, P.D., Ryan, D.H., Condemi, J.J., Ruszkowski, R.J. and Abraham, G.N. (1989) "Clonal B cell expansions in patients with essential mixed cryoglobulinaemia", Clin. Exp. Immunol. 76, 54-60.
  • Meroni, P.L., Barcellini, W., Sinico, R.A., Fomasieri, A., Sguoni, C., lnvemizzi, F., D'Amico, G. and Zanussi, C. (1986) "In vitro synthesis of IgM rheumatoid factor by lymphocytes from patients with essential mixed cryoglobulinemia", Clin. Exp. Immunol. 65, 303-310.
  • Curry, M.R. Golden-Mason, L., Nolan, N., Parfrey, N.A., Hegany, J.K. and O'Farrelly, C. (2000) "Expansion of peripheral blood CDS+ B cells is associated with mild disease in chronic hepatitis C virus infection", J. Hepatol. 32, 121-125.
  • De Re, V., De Vita, S., Marzotto, A., Gloghim, A., Pivetia, B., Gasparotto, D., Cannizzaro, R., Carbone, A. and Boiocchi, M. (2000) "Pre-malignant and malignant lymphoproliterations in an HCV-infected type II mixed cryoglohulincmic patient are sequential phases of an antigen-driven pathological process", Int. J. Cancer 87, 211-216.
  • Franzin, F., Efremov, D.G., Powzato, G., Tulissi, P., Balista, F. and Burrone, O.R. (1995) "Clonal B-cell expansions in peripheral blood of HCV-infectcd patients", Br. J. Haematol 90, 548-552.
  • Santini, G.F., Crovatto, M., Giannini, F., Bortolin, M.T., Mazzaro, C. and Invernizzi, F. (1998) "Hepatitis C virus and immunuglobulin gene rearraneements: an early step in lymphomagenesis?", Acta Haematol. 100, 117-122.
  • Mosnier, J.E., Degott, C., Marcellin, P., Henin, D., Erlinger, S. and Benharnou, J.P. (1993) "The intraportal lymphoid nodule and its environment in chronic hepatitis C: an immunohistochemical study", Hepatoloy 17, 366-371.
  • Monteverde, A., Ballarè, M. and Pileri, S. (1997) "Hepatitic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia", Springer Semin Immunopathol. 19, 99-110.
  • Murakami, J., Shimizu, Y., Kashii, Y., Kato, T., Minemura, M., Okada, K., Nambu, S., Takahara, T., Higuchi, K., Maeda, Y., Kumada, T. and Watanabe, A. (1999) "Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C", Hepatology 30, 143-150.
  • Sansonno, D., De Vila, S., Iacobelli, A.R., Cornacchiulo, V., Boiocchi, M. and Dammacco, F. (1998) "Clonal analysis of intrahepatic B cells from HIV-infected patients with and without mixed cryoglobulinemia", J. Immunol. 160, 3594-3601.
  • Magalini, A.R., Facchetli, F., Salvi, L., Fontana, L., Puoti, M. and Scarpo, A. (1998) "Clonality of B-cells in portal lymphoid infiltrates of HCV-infected livers", J Pathol. 185, 86-90.
  • Racanelli, V., Sansonno, D., Piccoli, C., D'Amore, F.P., Tucei, F.A. and Dammacco, F. (2001) "Molecular characterisation of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients", J. Immunol. 167, 21-29.
  • Mouteverde, A., Sabattini, E., Poggi, S., Ballaré, M., Bertoncelli, M.C., De Vivo, A., Briskomatis, A., Roncador, G., Falini, B. and Pileri, S. (1995) "Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type Il is characterized by a monoclonal B-cell proliferation", Leuk. Lymph. 20, 119-124.
  • Rasul, I., Sheperd, F.A., Kamel-Reid, S., Krajden, M., Pantalony, D. and Heathcote, E.J. (1999) "Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia", Hepatology 29, 543-547.
  • De Vita, S. De Re, V., Gasparotto, D. Ballarè, M., Pivetta, B., Ferraccioli, G., Pileri, S., Boiocehi, M. and Monteverde, A. (2000) "Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia", Arthritis Rheum. 43, 94-102.
  • Silvestri, F. and Baccarani, M. (1997) "Hepatitis C virus-related lymphomas", Br. J. Haematol. 99, 475-480.
  • Luppi, M., Ferrari, M.G., Bonaccorsi, G., Lougo, G., Narni, E., Baruzzi, P., Marasea, R., Mussini, C. and Torelli, G. (1996) "Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia", Leukemia 10, 351-355.
  • Silvestri, F., Pipan, C., Barillari, G., Zaia, E., Fanin, R., lnfanti, L., Russo, D., Falasca, E., Botta, G.A. and Baccarani, M. (1996) "Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders", Blood 87, 4296-4301.
  • Di Stasi, M., Sbolli, G., Fomari, E., Cavanna, L., Russi, S., Buscarini, E., Civerdi, G., Vallisa, D., Berte, R. and Busearini, L. (1994) "Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors", Oncology 51, 459-464.
  • Lombardo, L., Rota Scalahrini, D., Vineis, P. and De la Pierre, M. (1993) "Malignant lymphoproliferative disorders in liver cirrhosis", Ann. Oncol. 4, 245-250.
  • De Vita, S., Sacco, C., Sansonno, D., Gloghini, A., Dammacco, F., Crovatto, M., Santini, G., Dolcetti, R., Boiocchi, M., Carbone, A. and Zagonel, V. (1997) "Characterisation of overt B-cell lymphomas in patients with hepatitis C virus infection", Blood 90, 776-782.
  • De Vita, S., Zagonel, V., Russo, A., Rupolo, M., Cannizzario, R., Chiara, G., Boiocchi, M., Carbone, A. and Franceschi, S. (1998) "Hepatitis C virus. non-Hodgkin's lymphomas and hepatocellular carcinoma". Br. J. Cancer 77, 2032-2035.
  • De Vita, S., Sansonno, D., Dolcelli, R., Ferraccioli, G., Carbone, A., Comacchiulo, V., Santini, G., Crovatto, M., Gloghini, A., Dammacco, F. and Boiocchi, M. (1995) "Hepatitis C virus within a malignaut lymphoma lesion in the course of type II mixed cryoglobulinemia", Blood 86, 1887-1892.
  • Sansonno, D., De Vila, S., Comacchiulo, V., Carbone, A., Boiocchi, M and Dammacco, F. (1996) "Detection and distribution of hepatitis C-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferalion", Blood 88, 4638-4645.
  • De Vila, S., De Re, V., Sansonno, D., Sorrenlino, D., La Corte, R., Pivettii, B., Gasparotlo, D., Racanelli, V., Marzotto, A., Labombarda, A., Gloghini, A., Ferraccioli, G., Monteverde, A., Carbone, A., Darnmacco, F. and Boiocchi, M. (2000) "Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis", Hepatology 31, 182-189.
  • Agnello, V. (1995) "The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection", Scand. J. Immunol 42, 179-184.
  • Agnello, V. (1997) "Hepatitis C virus infection and type II cryoglobulinemia: an immunological perspective". Hepatology 26, 1375-1379.
  • Martin, T., Duffy, S.F., Carson, D.A. and Kipps, T.J. (1992) "Evidence for somatic selection of natural autoantibodies", J. Exp. Med 175, 983-991.
  • Martin, T., Crouzier, R., Weber, J.-C., Kipps, T.J. and Pasquali, J.L. (1994) "Structure-function studies on a polyreactive (Natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain". J. Immunol. 152, 5988-5996.
  • De Re, V., De Vita, S., Marzotto, A., Rupolo, M., Gloghini, A., Pivetta, B., Gasparotto, D., Carbone, A. and Boiocchi, M. (2000) "Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cyoglobulinemia", Blood 96, 3578-3584.
  • Ivanovski, M., Silvestri, R. Pozzalo, G., Anand, S., Mazzaro, C., Burrone, O.R. and Efremov, D.G. (1998) "Somatic hypermutation, clonal diversity, and preferential expression of the VH 51pt/VI. kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas", Blood 91, 2433-2442.
  • Marasca, R., Vaccari, P., Luppi, M., Zucchini, P., Custelli, I., Barozzi, P., Cuoghi, A. and Torelli, G. (2001) "Immunoglobulin gene mutations and frequent use of VHI-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma", Am. J. Pathol. 159, 253-261.
  • Gorevic, P.D. and Frangione, B. (1991) "Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and tymphoproliferative diseases", Semin. Heamatol. 28, 79-94.
  • Knight, G.B., Agnello, V., Bonagura, V., Barnes, J.L., Panka, D.J. and Zhang, Q.X. (1993) "Human rheumatoid factor cross-idiotypes IV. Studies on WA Xld-positive IgM without rheumatoid factor activity provide evidence that the WA XId is not unique to rheumatoid factors and is distinct from the 17.109 and G6 XIds", J. Exp. Med. 178, 1903-1911.
  • Bwretzen, M., Randen, I. ?dU=00E1rský, E., Førre, Ø., Natvig, J.B. and Thompson, K.M. (1994) "Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions", Proc. Natl Acad. Sci. USA 91, 12917-12921.
  • Hubert Chan, C., Handlock, K.G., Foung, S.K. and Levy, S. (2001) "VHI-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen", Blond 97, 1023-1026.
  • Sulton, B.J., Corper, A.L., Sohi, M.K., Jefferis, R., Beale, D. and Taussig, M.J. (1998) "The structure of a human rheumatoid factor bound to IgG Fc", Adv. Exp. Med. Biol. 435, 41-50.
  • Treon, S.P., Raje, N. and Anderson, K.C. (2000) "Immunotherapeutic strategies for the treatment of plasma cell malignancies", Semin. Oncol. 27, 598-613. References
  • Clino, M.J. and Golde, D.W. (1978) "Immune suppression of hematopoiesis", American Journal of Medicine 64, 301-310.
  • Shastri, K.A. and Logue, G.L. (1993) "Autoimmune neutropenia", Blood 81, 1984-1995.
  • Charles, R.J., Subo, K.M., Kidd, P.C. and Abkowitz, J.L. (1996) "The pathophysiology of pure red cell aplasia: implications for therapy", Blood 87, 4831-4838.
  • Nidorf, D. and Saleem, A. (1990) "Immunosuppressive mechanisms in pure red cell aplasia--a review", Annals of Clinical and Laboratory Science 20, 214-219.
  • Dessypris, E.N. (1991) "The biology of pure red cell aplasia", Seminors in Hematology 28, 275-284.
  • Murphy, M.F., Izaguirre, C.A., Dhaliwal, H., Wrigley, P.F.M. and Waters, A.M. (1984) "Pure red cell aplasia--evidence for an inhibitory action of the bone marrow adherent cell layer", Clinical and Laboratory Haematology 6, 61-67.
  • Currie, M.S., Weinberg, J.B., Rustagi, P.K. and Logue, G.L. (1987) "Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neurropenias: use of HL-60 cells as targets", Blood 69, 529-536.
  • Hartnian, K.R., LaRussa, V.R. Rothwell, S.W., Atolagbe, T.O., Ward, F.T. and Klipple, G. (1994) "Antibodies to myeloid precursor cells in autoimmune neutropenia", Blood 84, 625-631.
  • Hoffman, R., Zaknoen, S., Yang, H.H., Brutto, C., LoBuglio, A.E., Arrowsmith, J.B. and Prchal, J.T. (1985) "An antibody cytotoxic to megakaryocyte progenitor cells in a patirnt with immune thrombocytopenic purpura". New England Journal of Medicine 312, 1170-1174.
  • Abgrall, J.R. Berthou, C., Sensebe, L., Le Niger, C. and Escoffre, M. (1993) "Decreased in vitro megakaryocyte colony formation in chronic idiopathic thrombocytopenic purpura", British Journal of Haematology 85, 803-804.
  • lkehara, S. (1998) "Autoimmune diseases as stem cell disorders: normal stem cell transplant for their treatment", International Journal of Molecular Medicine 1, 5-16.
  • Ikebara, S. (2001) "Treatment of autoimmune diseases by hematopoietic stem cell transplantation", Experimental Hematology 29, 661-669.
  • Tyndall, A. and Gratwohl, A. (1997) "Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group fur Blood and Marrow Transplantation (EBMT)", British Journal of Rheumatology 36, 390-392.
  • Tyndall, A., Passweg, J and Gratwohl, A. (2001) "Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000", Annals of Rheumatic Diseases 60, 702-707.
  • Gibsou, F.M. and Gordon-Smith, E.C. (1990) "Long-term culture of aplastic anaemia bone marrow", British Journal of Haematology 75, 421-427.
  • Papadaki, HA., Gibson, P.M., Rizzo, S., Gordon-Smith, E.C. and Marsh, J.C. (2000) "Assessment of bone marrow stem cell reserve and function and stromal cell function in patients with autoimmune cytopenias", Blood 96, 3272-3275.
  • Weaver, A., Ryder, W.D. and Testa, N.G. (1997) "Measurement of long-term culture initiating cells (LTC-ICs) using limiting dilution: comparison of endpoints and stromal support", Experimental Hematology 25, 1333-1338.
  • Fazekas de St.Groth, S. (1982) "The evaluation of limiting dilution assays", Journal of Immunological Methods 49, 11-23.
  • Sutherland, H.J., Eaves, C.J., Eaves, A.C., DragOwska, W. and Lansdorp, P.M. (1989) "Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro", Blood 74, 1563-1570.
  • Marsh, J.C., Chang, J., Testa, N.G., Hows, J.M. and Dexter, T.M. (1991) "In vitro assessment of marrow stem cell and stromal cell function in aplastic anaemia". British Journal of Haematology 78, 258-267.
  • Roberts, A.W. and Nicola, N.A. (1997) "Granulocyte colony-stimulating factor", In: Garland, J.M., Quesenberry, P.J. and Hilton, D.J., eds. Colony-Stimulating Factors: Molecular and Cellular Biology (Marcel Dekker, New York), pp 203-226.
  • Lira, S.H., Kell, J., al-Sabah, A., Bashi, W. and Bailey-Wood, R. (1997) "Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura", Lancet 349, 475.
  • Musso, M., Porretto, F., Crescimanno, A., Bondi, F., Polizzi, V. and Scalone, R. (2001) "Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease". American Journal of Hematilogy 66, 75-79.
  • Rabusin, M., Andolina, M., Maxirnova, N., Lepore, L., Parco, S., Tuveri, G. and Jankovic, G. (2000) "Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease". Haematologica 85, 81-85.
  • Paillard, C., Kanold, J., Halle, P., Yakouben, K., Boiret, N., Rapatel, C., Berger, M., Malpuech, G. and Demeocq, F. (2000) "Two-step immunoablative treatment with autologous peripheral blood CD34(+) cell transplantation in an 8-year-old boy with autoimmune haemolytic anaemia", British Journal of Haematology 110, 900-902.
  • Marmont, A.M. (1998) "Stem cell therapy for severe autoimmune diseases: the present situation". Haema 1, 21-26.
  • Skoda, R.C., Tichelli, A., Tyndall, A., Hoffmann, T., Gillessen, S. and Gratwohl, A. (1997) "Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia", British Journal of Haematology 99, 56-57.
  • Marmont, A.M., van Lint, M.T., Occhini, D., Lamparelli, T. and Bacigalupo, A. (1998) "Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura". Bone Marrow Transplantation 22, 827-828.
  • Purtilo, D.T., Sakamoto, K., Bamabei, V., Seeley, J., Bechtold, T., Rogers, G., Yelz, J. and Harada, S. (1982) "Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry". American Journal of Medicine 73, 49-56.
  • Brown, K.E., Tisdale, J., Barren, A.J., Dunbar, C.E. and Young, N.S. (1997) "Hepatitis-associated aplastic anemia", New England Journal of Medicine 336, 1059-1064.
  • Osaki, M., Matsubara, K., Iwasaki, T., Kurata, T., Nigami, H., Harigaya, H. and Baba, K. (1999) "Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease", Annals of Hematology 78, 83-86.
  • Roffe, C. Cabill, M.R., Samanta, A., Bricknell, S. and Durrant, S.T. (1991) "Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism?". British Journal of Rheumatology 30, 301-304.
  • Bailey, F.A., Lilly, M., Bertoli, L.F. and Bau, G.V. (1989) "An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia", Arthritis and Rheumatism 32, 901-905.
  • Scadden, D.T., Zeira, M., Woon, A., Wang, Z., Schieve, L., Ikeuchi, K., Lim, B. and Groopman, J.E. (1990) "Human immunodeficiency virus infection of human bone marrow stromal fibroblasts", Blood 76, 317-322.
  • Schwanz, G.N., Kessler, S.W., Rothwell, S.W., Burrell, L.M., Reid, T.J., Meltzer, M.S. and Wright, D.G. (1994) "Inhibitory effects of HTV-l-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures", Experimental Hematology 22, 1288-1296.
  • Moses, A.V., Williams, S., Heneveld, M.L., Strussenberg, J., Rarick, M., Loveless, M., Bagby, G. and Nelson, J.A. (1996) "Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors", Blood 87, 919-925.
  • Courtney, P.A., Crockard, A.D., Williamson, K., Irvine, A.E., Kennedy, R.J. and Bell, A.L. (1999) "Increased apoptoric peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA. and neutropenia", Annals of Rheumatic Diseases 58, 309-314.
  • Amasaki, Y., Kobayashi, S., Takeda, T., Ogura, N., Jodo, S., Nakabayashi, T., Tsutsumi, A., Fujisaku, A. and Koike, T. (1995) "Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia", Clinical and Experimental Immunology 99, 245-250.
  • Liu, H., Ozaki, K., Matsuzaki, Y. Abe, M., Kosaka, M. and Saito, S. (1995) "Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosus (SLE)". Clinical and Experimental Immunology 100, 480-485.
  • Otsuka, T., Okamura, S., Harada, M., Ohhara, N., Hayashi, S., Yamaga, S., Nagasawa, K. and Nine, Y. (1988) "Multipoint hemopoietic progenitor cells in patients with systemic lupus erythematosus". Journal of Rheumatology 15, 1085-1090.
  • Kiely, P.D., McGuckin, C.P., Collins, D.A., Bevan, D.H. and Marsh, J.C. (1995) "Erythrocyte aptasia and systemic lupus erythematosus". Lupus 4, 407-411.
  • Atta, M.S., Powell, R.J. and Todd, I. (1994) "The influence of antifibronectin antibodies on interactions involving extracellular matrix component and cells: a possible pathogenic mechanism", Clinical and Experimental Immunology 96, 26-30.
  • Papadaki, H.A., Boumpas, D.T., Gibson, P.M., Jayne, D.R., Axford, J.S., Gordon-Smith, E.G., Marsh, J.C.W. and Eliopoulos, G.D. (2001) "Increased apoptosis of bone marrow CD34+ cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus", British Journal of Haematology 115, 167-174.
  • Philpott, N.J., Turner, A.J., Scopes, J., Westby, M., Marsh, J.C., Gordon-Smith, E.G., Dalgleish, A.G. and Gibson, EM. (1996) "The use of 7-amino actinomycin D in identifying apoplosis: simplicity of use and broad spectrum of application compared with other techniques". Blood 87, 2244-2251.
  • Nagafuji, K., Shibuya, T., Harada, M., Mizuno, S., Takenaka, K., Miyamoto, T. Okamura, T., Gondo, H. and Niho, Y. (1995) "Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells", Blood 86, 883-889.
  • Saheki, K., Fujiraori, Y., Takemolo, Y. and Kakishita, E. (2000) "Increased expression of Fas (APO-1, CD95) on CD34+ haematopoietic progenitor cells after allogeneic bone marrow transplantation". British Journal of Haematology 109, 447-452.
  • Nagafuji, K., Takenaka, K., Shibuya, T., Harada, M. and Niho, Y. (1996) "Fas antigen (CD95) and hematopoietic progenitor cells", Leukemia and Lymphoma 24, 43-56.
  • Aderka, D., Wysenbeek, A., Engelmann, H., Cope, A.P., Brennan, F., Molad, Y. Hornik, V., Levu, Y, Maini, R.N. and Feldmam, M. (1993) "Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus". Arthritis and Rheumatism 36, 1111-1120.
  • Lacki, J.K. Leszczynski, P., Kelemen, J., Muller, W. and Mackiewicz, S.H. (1997) "Cytokine concentration in serum of lupus erytbematosus patients: the effect on acute phase response", Journal of Medicine 28, 99-107.
  • Kelley, V.R. and Wuthrich, R.P. (1999) "Cytokines in the pathogenesis of systemic lupus erythematosus". Seminars in Nephrology 19, 57-66.
  • Alvarado-de, B., Alcocer-Varela, J., Richaud-Patin, Y., Alarcon-Segovia, D. and Llorente, L. (1998) "Differential oncogene and TNF-alpha mRNA expression in bone marrow cells from systemic lupus erythematosus patients", Scandinavian Journal of Immunology 48, 551-556.
  • Shaughnessy, P.J., Ririe, D.W., Omstein, D.L., Kissack, B., Bickford, D.J., Molina, R., Lanzkron, S., Bachier, C., Nanez, A. and LeMaistre, C.F. (2001) "Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue", Bone Marrow Transplantation 27, 221-224.
  • Otstika, T., Nagasawa, K., Harada, M. and Niho, Y. (1993) "Bone marrow microenvironment of patients with systemic lupus erythematosus", Journal of Rheumatology 20, 967-971.
  • Starkebaum, G., Singer, I.W. and Arend, W.P. (1980) "Humoral and cellular immune mechanisms of neutropenia in patients with Felty's syndrome", Clinical and Experimental Immunology 39, 307-314.
  • Goldschmeding, R., Breetlveld, P.C., Engelfriet, C.P. and von dem Borne, A.E. (1988) "Lack of evidence for the presence of neutrophil autoantibodies in the serum of patients with Felty's syndrome", British Journal of Haematoloy 68, 37-40.
  • Coakley, G., Iqbal, M., Brooks, D., Panayi, G.S. and Lanchbury, J.S. (2000) "CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Helty's and large granular lymphocyte syndromes", Arthritis and Rheumatism 43, 834-843.
  • Jongen-Lavrencic, M., Peelers, H.R., Wognum, A., Vreugdenhil, C., Breedveld, E.C. and Swaak, A.J. (1997) "Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease". Journal of Rheumatology 24, 1504-1509.
  • Kotake, S., Higaki, M., Sato, K., Himeno, S., Monta, H., Kim, K.J., Nara, N., Miyasaka, N., Nishioka, K. and Kashiwazaki, S. (1992) "Detection of myeloid precursors (granulocyte/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints", Journal of Rheumatology 19, 1511-1516.
  • Tomita, T., Kashiwagi, N., Shimaoka, Y., Ikawa, T., Tanabe, M., Nakagawa, S., Kawumura, S., Denno, K., Owaki, H. and Ochi, T. (1994) "Phenotypic characteristics of bone marrow cells in patients with rheumatoid arthritis", Journal of Rheumatology 21, 1608-1614.
  • Hirohata, S., Yanagida, T., Itoh, K., Nakamura, H., Yoshino, S., Tomita, T. and Ochi, T. (1996) "Accelerated generation of CD14+ inonocyle-lineage cells from the hone marrow of rheumatoid arthritis patients". Arthritis and Rheumatism 39, 836-843.
  • Tomita, T., Shimaoka, Y., Kashiwagi, N., Mashimoto, H., Kawamura, S., Lee, S.B., Nakagawa, S., Shiho, O., Hayashida, K. and Ochi, T. (1997) "Enhanced expression of CD14 antigen on myeloid lineage cells derived from the hone marrow of patients with severe rheumatoid arthritis". Journal of Rheumatology 24, 465-469.
  • Kaisho, T., Oritani, K., Ishikavva, J., Tanabe, M., Muraoka, O., Ochi, T. and Hirano, T. (1992) "Human bone marrow stromal cell lines from myeloma and rheumatoid arthritis that can support murine pre-B cell growth", Journal of Immunology 149, 4088-4095.
  • Nakagawa, S., Toritsuka, Y., Wakitani, S., Denno, K., Tomila, T., Owaki, H., Kimura, T., Shino, K. and Ochi, T. (1996) "Bone marrow stromal cells contribute to synovial cell proliferation in rats with collagen induced arthritis", Journal of Rheumatology 23, 2098-2103.
  • Sen, M., Laulerbach, K., EI-Gabalawy, H., Frestein, G.S., Torr, M. and Carson, D.A. (2000) "Expression and function of wingless and frizzled homologs in rheumatoid arthritis", Proceedings of National Academy of Sciences USA 97, 2791-2796.
  • Santiago-Schwarz, E., Sullivan, C., Rappa, D. and Carsuns, S.E. (1996) "Distinct alterations in lineage committed progenitor cells exist in the peripheral blood of patients with rheumatoid arthritis and primary Sjogren's syndrome", Journal of Rheumatology 23, 439-446.
  • Tomita, T., Takeuchi, E., Toyosaki-Maeda, T. Oku, H., Kaneko, M., Takano, H., Sugamoio, K., Ohzono, K., Suxuki, K. and Ochi, T. (1999) "Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis", Rheumatology (Oxford) 38, 854-863.
  • Berthelol, J.M., Bataille, R., Maugars, Y. and Prost, A. (1996) "Rheamatoid arthritis as a bone marrow disorder", Seminars in Arthritis and Rheumatism 26, 505-514
  • Papadaki, H.A., Boumpas, D.T., Kritikos, H., Kouroumali, H., Coutala, H., Gemetzi, C., Lydataki, N. and Eliopoulos, G.D. (2001) "Bone marrow stem cell reserve and function and stromal cell function are defective in patients with rheumatoid arthritis. Evidence for a TNF-alpha effect", The Hematology Journal 1(Suppl. 1). 193.
  • Snowden, J.A., Mink, V., Cooley, M., Zaunders, J., Keir, M., Wright, L., Milliken, S.T., Brooks, P.M. and Biggs, J.C. (1998) "Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritis", British Journal of Huematology 103, 601-609.
  • Choy, E.H. and Panayi, G.S. (2001) "Cytokine pathways and joint inflammation in rheumatoid arthritis". New England Journal of Medicine 344, 907-916.
  • Knight, D.M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Seallon, B., Moore, M.A., Vileek, J. and Daddona, P. (1993) "Construction and initial characterization of a mause-buman chimeric anti-TNF antibody", Molecular Immunology 30, 1443-1453. References
  • Van den Berghc H., Cassiman, J.J., David, G., Fryas, J.P., Michaux, J.L., and Sokal, G. (1974) "Distinct haematological disorder with deletion of long and of no. 5 chromosome", Nature 251, 437-438.
  • Sokal, G., Michaux, J.L., Van Den Berghe, H., Cordier, A., Rodhuin, J., Ferrant, A., Moriau, M., De Bruyere, M. and Sonnet, J. (1975) "A new hematologic syndrome with a distinct karyotype: the 5q chromosome", Blood 46, 519-531.
  • Mahmood, T., Robinson, W.A., Hamstra, R.D. and Wallner, S.F. (1979) "Macrocytic anemia, thrombocytosis and nonlobulated megakaryocytes: the 5q - syndrome, a distinct entity", Am. J. Med. 66, 946-950.
  • Van den Berghe, H., Vermaelen, K., Mecucci, C., Barhieri, D. and Tricol, G. (1985) "The 5q anomaly", Cancer Genet. Cytogenet. 17, 189-255.
  • Lewis, S., Oscier, D., Boultwood, J., Ross, R., Filchett, M., Rack, K., Abrabamson, G. Buckle, V. and Wamseoat, J.S (1995) "Hemalological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion". Am. J. Hematol. 49, 194-200.
  • Germing, U., Gattermann, N., Strupp, C., Aivado, M., and AuI, C. (2000) "Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients". Leuk. Res. 24, 983-992.
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. and Bloomfield, C.D. (1999) 'The World Health Organisation classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting. Airlie House. Virginia. November. 1997". Ann. Oncol. 10, 1419-1432.
  • Dewald, G.W., Davis, M.R. Pierre, R.V., O'Fallon, J.R. and Hoagland, H.C. (1985) "Clinical characteristics and prognosis of 50 patients with a mycloproliferative syndrome and deletion of part of the long arm of chromosome 5", Blood 66, 189-197.
  • Teerenhovi, L. (1987) "Specificity of haematological indicators for "5q - syndrome" in patients with myelodysplastic syndromes", Eur. J. Haematol. 39, 326-330.
  • Mathew, P., Tefferi, A., Dewald, G.W., Goldberg, S.L., Su, J., Hoagland, H.C. and Noel, P. (1993) "The 5q syndrome: a single-institution study of 43 consecutive patients". Blood 81, 1040-1045.
  • Boultwood, J., Lewis, S. and Wainscoat, J.S. (1994) "The 5q -- syndrome", Blood 84, 3253-3260.
  • Bennett, J.M., Catewsky, D., Daniel, M.T. Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1982) "Proposals for the classification of the myelodysplastic syndromes", Br. J. Haematol. 51, 189-199.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. and Sultan, C. (1985) "Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American British Cooperative Group", Ann. Inter. Med. 103, 620-625.
  • Rosati, S., Mick, R., Xu, F., Stonys, E., Le Beau, M.M., Larson, R. and Vardiman, J.W. (1996) "Refractory cytopenia with multilineage dysplasia: further characterization of an "unclassifiable" myelodysplastic syndrome", Leukemia 10, 20-26. sec comments.
  • Brunning, R.D. and McKennu, R.W. (1993) "Tumors: of the bone marrow", in: Rosal, J., ed. Atlas of Tumor Pathology (Armed Forces Institute of Pathology. Washington, DC).
  • Kaplan, K. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", J. Am. Statist. Assoc. 53, 457.
  • S-Plus 4 Guide to Statistics. SeattIe: Mathsoft, Data Analysis Products Division. 1998.
  • Giles, E.J., O'Brien, S.M. and Keating, M.J. (1998) "Chronic lymphocytic leukemia in (Richter's) transformation", Semin. Oncol. 25, 117-125.
  • Robenson, L.E., Pugh, W., O'Brien, S., Kantarjian, H., Hirsch-Ginsberg, C. Cork, A., McLaughlin, P., Cabanillas, K and Keating, M.J. (1993) "Richter's syndrome: a report on 39 patients", J. Clin. Oncol. 11, 1985-1989.
  • Keating, M.J., Kantarjian, H., Talpaz, M., Redman, J., Koller, C., Barlogie, B., Velasquez, W., Plunkell, W., Freireich, E.J. and McCredie, K.B. (1989) "Fludarahine: a new agent with major activity against chronic lymphocytic leukemia", Blood 74, 19-25.
  • Keating, M.J. (1990) "Fludarabine phosphate in the treatment of chronic lymphocytic leukemia", Semin. Oncol. 17, 49-62.
  • Keating, M.J., Kantarjian, H., O'Brien, S., Koller, C. Talpaz, M., Schachner, J., Childs, C.C, Freireich, B.J. and McCredie, K.B. (1991 ) "Hudarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia", J. Clin. Oncol. 9, 44-49.
  • Robertson, L.E., Huh, Y.O., Butler, J.J., Pugh, W.C., Hirsch-Ginsberg, C., Stass, S., Kantarjian, H. and Keating, M.J. (1992) "Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis". Blood 80, 29-36.
  • Robertson, L.E., O'Brien, S., Kantarjian, H., Koller, C., Beran, M., Andreeff, M., Lemer, S. and Keating, M.J. (1995) "Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia", Leukemia 9, 943-945.
  • Gregory, S.A., Vose, J., Modiano, M., Kraemer, K., Rifkin, R., Rubin, A., Menduni, T. and Cihalie, R. (2001) "Mitoxantrone and fludarabine in the treatment of patients with non-Hodgkin's lymphoma failing primary therapy with a doxorubicinor mitoxantrone-containing regimen", Leuk. Lymphoma 40, 315-324.
  • Santini, G., Nati, S., Spriano, M., Gallamini, A., Pierluigi, D., Congiu, A.M., Truini, M., Rubagotti, A., Chisesi, T., Vimercati, R., Rossi, E., Sertoli, M.R., Mallei, D., Marino, G. and Gobbi, M. (2001) "Rudarabine in combination with cydophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma", Haematologica 86, 282-286.
  • Zinzani, P.L., Magagnoli, M., Moretti, L., Battista, R., Ronconi, F., De Renzo, A., Zaccaria, A., Gentilini, P., Guardigni, L., Gherlinzoni, K, Cellini, C., Fattori, P.P., Bendandi, M., Bocchia, M., Aitini, E. and Tura, S. (1999) "Fludarabine-based chemotherapy in untreated manlJe cell lymphomas: an encouraging experience in 29 patients", Haematologica 84, 1002-1006.
  • Hallek, M., Schmitt, B., Wilhelm, M., Busch, R., Krober, A., Fostitsch, H.P., Sezer, O., Herold, M., Knauf, W., Wendtner, C.M., Kuse, R., Freund, M., Franke, A., Schriever, E., Nerl, C., Dohner, H., Thiel, E., Hiddemann, W., Brittinger, G. and Emmerich, B. (2001) "Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group". Br. J. Haematol. 114, 342-348.
  • Hochster, H.S., Oken, M.M., Winter, J.N., Gordon, L.I., Raphael, B.C., Bennett, J.M. and Cassileth, P.A. (2000) "Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and long-term follow-up-a report from the Fastem Cooperative Oncology Group", J. Clin. Oncol. 18, 987-994.
  • Cabanillas, F. (1991) "Experience with salvage regimens at M.D. Anderson Hospital", Ann. Oncol. 2(Suppl. 1), 31-32.
  • Gandhi, V. Kemena, A., Keating, M.J. and Plunkett, W. (1992) "Fludarabine infusion potentiates arabinosyleytosine metabolism in lymphocytes of patients with chronic lymphocytic leukemia", Cancer Res. 52, 897-903.
  • Seymour, J.F., Huang, P., Plunkell, W. and Gandhi, V. (1996) "Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule", Clin. Cancer. Res. 2, 653-658.
  • Giles, F.J, O'Brien, S.M., Santini, V, Gandhi, V., Plunkett, W. Seymour, J.F. Robertson, L.E., Kantarjian, H.M. and Keating, M.J. (1999) "Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II study", Leuk. Lymphoma. 36, 57-65.
  • Seymour, J. F., Grigg, A. Szer, J. and Fox, R. (1995) "Fludarabine, cisplatin and ara-C: an active regimen in patients with anthracyctin-refractory intermediate-grade non-Hodgkin's lymphoma", Blood 86(ASH), 55a.
  • Kimby, E., Brandi, L., Nygren, P. and Glimelius, B. (2001) "A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia", Acta Oncol. 40, 224-230.
  • Levy, V., Porcher, R., Delabarre, F., Leporrier, M., Cazin, B. and Chevrel, S. (2001) "Evaluating treatment strategies in chronic lymphocytic leukemia: use of quality-adjusted survival analysis", J. Clin. Epidemiol. 54, 747-754.
  • Hamblin, T.J. (2001) "Achieving optimal outcomes in chronic lymphocytic leukaemia", Drugs 61, 593-611.
  • Fisher, R.I. (2000) "Current therapeutic paradigm tor the treatment of non-Hodgkin's lymphoma", Semin. Oncol 27, 2-8.
  • Cohen, K. and Scadden, D.T. (2001) "Non-Hodgkin's lymphoma: pathogenesis, clinical presentation, and treatment", Cancer Treat. Res. 104, 201-230.
  • Brandt, S.J., Peters, W.P., Atwater, S.K., Kurtzberg, J., Borowitz, M.J., Jones, R.B., Shpall, E.J., Bast, Jr. R.C., Gilbert, C.J. and Octte, D.H. (1988) "Effect of recombinant human granulocyte-macrophage colony stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation", N. Engl. J. Med. 318, 869-876.
  • Giles, K.J. (1998) "Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants", Clin. Infect. Dis. 26, 1282-1289.
  • Peters, B.G., Adkins, D.R., Harrison, B.R., Velasquez, W.S., Dunphy, F.R., Petruska, P.J., Bowers, C.E., Niemeyer, R., McIntyre, W., Vrahnos, D., Auberry, S.E. and Spitzer, G. (1996) "Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis", Bone Marrow Transplant 18, 93-102.
  • Goodman, M.G., Spinosa, J.C., Saven, A., Piro, L.D. and Wonnsley, S. (1996) "New perspectives on the approach to chronic lymphocytic leukemia", Leak, Lymphoma 22, 1-10.
  • Aderka, D., Maor, Y., Novick, D., Engelmann, H., Kahn, Y., Levo, Y, Wallach, D. and Revel, M. (1993) "Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta", Blood 81, 2076-2084.
  • van Kooten, C., Rensink, I., Aarden, L. and van Oers, R. (1993) "Differentiation of purified malignant B cells induced by PMA or by activated normal T cells", leukemia 7, 1576-1584.
  • Kamolsky, l.N. (2000) "Cytogenetic abnormalities in chronic lymphocytic leukemia", Folia Med. 42, 5-10.
  • Dohner, H., Slilgenbauer, S., Dohner, K., Bealz, M. and Lichter, P. (1999) "Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysts", J. Mol. Med. 77, 266-281.
  • Dabaja, B., O'Brien, S., Kantarjian, H., Cortes, J., Thomas, D., Albitar, M., Schielte, E., Faded, S., Sarris, A., Keatiug, M. and Giles, F. (2001) "Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoxome). and dexamethasone (hyperCVXD) regimen in Richter's syndrome", Leuk. Lymphoma 42, 329-338.
  • Hideshima, T., Richardson, P., Chauhan, D., Palomhella, V.J., Elliott, P.J., Adams, J. and Anderson, K.C. (2001) "The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells". Cancer Res. 61, 3071-3076.
  • Giles, F.J., Cortes, J.E., Baker, S.D., Thomas, D.A., O'Brien, S., Smith, T.L., Beran, M., Bivins. C., Jolivet, J. and Kantarjian, H.M. (2001) "Troxacitabine, a novel dioxolane nucleoside analog, has activity in patients with advanced leukemia", J. Clin. Oncol. 19, 762-771.
  • Hidalgo, M. and Rowinsky, E.K. (2000) "The rapamycin-sensitive signal transduction pathway as a target for cancer therapy", Onconenc 19, 6680-6686.
  • Mendel, D.B., Schreck, R.E., West, D.C., Li, G., Strawn, L.M., Tanciongco, S.S., Vasile, S., Shawver, L.K. and Cherringion, J.M. (2000) 'The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function", Clin. Cancer Res. 6, 4848-4858.
  • Webb, A., Cunningham, D., Cotter, F., Clarke, P.A., di Stefano, F., Ross, P., Corho, M. and Dziewanowska, Z. (1997) "BCL-2 antisense therapy in patients with non-Hodgkin lymphoma", Lancet 349, 1137-1141.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.